Recombinant 52 kDa Ro(SSA) ELISA detects autoantibodies in Sjogren's syndrome sera that go undetected by conventional serologic assays

Journal of Rheumatology

Volumn 24, Issue 5, 1997, Pages 860-866

  McCauliffe, Daniel P ^a,d   Wang, Lixiang ^a   Satoh, Minoru ^b   Reeves, Westley H ^b   Small, Daniel ^c  

^a Division of Dermatology   (United States)

^b Department of Rheumatology ^*

^c Sarasota Arthritis Center   (United States)

^d UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

RO; SJOGREN'S SYNDROME; SSA

Indexed keywords

AUTOANTIBODY;

ANTIGEN ANTIBODY COMPLEX; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOBLOTTING; IMMUNODIFFUSION; IMMUNOPRECIPITATION; IMMUNOREACTIVITY; PRIORITY JOURNAL; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANTIBODY SPECIFICITY; AUTOANTIBODIES; AUTOANTIGENS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOBLOTTING; PRECIPITIN TESTS; RECOMBINANT PROTEINS; RIBONUCLEOPROTEINS; RNA, SMALL CYTOPLASMIC; SENSITIVITY AND SPECIFICITY; SJOGREN'S SYNDROME;

EID: 0030956064     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Talal N: Sjögren's syndrome and connective tissue diseases associated with other immunologic disorders. In: McCarty DJ, Koopman WJ, eds. Arthritis and Allied Conditions. Philadelphia: Lea & Febiger, 1993:1343-56.
2. Ramos-Remus C, Suarez-Almazor M, Russell AS: Low tear production in patients with diabetes mellitus is not due to Sjögren's syndrome. Clin Exp Rheumatol 1994;12:375-80.
3. Sreebny LM, Yu A, Green A, Valdini A: Xerostomia in diabetes mellitus. Diabetes Care 1992;15:900-4.
4. Martinez-Lavin M, Vaughn JH, Tan EM: Autoantibodies and the spectrum of Sjögren's syndrome. Ann Intern Med 1979;91:185-90.
5. Harley JB, Alexander EL, Bias WB, et al: Anti-Ro(SS-A) and anti-La(SS-B) in patients with Sjögren's syndrome. Arthritis Rheum 1986;29:196-206.
6. Ben-Chetrit E, Chan EKL, Sullivan KF, Tan EM: A 52-kD protein is a novel component of the SS-A/Ro antigenic particle. J Exp Med 1988;167:1560-71.
7. Ben-Chetrit E, Fox RI, Tan EM: Dissociation of immune responses to the SS-A(Ro) 52-kD and 60-kD polypeptides in systemic lupus erythematosus and Sjögren's syndrome. Arthritis Rheum 1990;33:349-55.
8. Deutscher SL, Harley JB, Keene JD: Molecular analysis of the 60-kDa human Ro ribonucleoprotein. Proc Natl Acad Sci USA 1988;85:9479-83.
9. Ben-Chetrit E, Gandy BJ, Tan EM, Sullivan KF: Isolation and characterization of a cDNA clone encoding the 60-kD component of the human SS-A/Ro ribonucleo-protein autoantigen. J Clin Invest 1989;83:1284-92.
10. Chan EKL, Hamel JC, Buyon JP, Tan EM: Molecular definition and sequence motifs of the 52-kD component of human SS-A/Ro autoantigen. J Clin Invest 1991;87:68-76.
11. Itoh K, Itoh Y, Frank MB: Protein heterogeneity in the human Ro/SSA ribonucleoproteins. The 52- and 60-kD Ro/SSA autoantigens are encoded by separate genes. J Clin Invest 1991;87:177-86.
12. Manoussakis MN, Kistis KG, Liu X, Aidinis V, Guialis A, Moutsopoulos HM: Detection of Anti-Ro(SSA) antibodies in autoimmune diseases: Comparison of five methods. Br J Rheumatol 1995;32:449-55.
13. Ricchiuti V, Briand JP, Meyer O, Isenberg DA, Pruijn G, Muller S: Epitope mapping with synthetic peptides of 52-kD SSA/Ro protein reveals heterogeneous antibody profiles in human autoimmune sera. Clin Exp Immunol 1994;95:397-407.
14. St. Clair EW, Burch JA Jr, Saitta M: Specificity of autoantibodies for recombinant 60-kD and 52-kD Ro autoantigens. Arthritis Rheum 1994;37:1373-9.
15. Clark G, Reichlin M, Tomasi TB: Characterization of a soluble cytoplasmic antigen reactive with sera from patients with systemic lupus erythematosus. J Immunol 1969;102:117-22.
16. Meilof JF, Bantjes I, DeJong J, Van Dam AP, Smeenk RJT: The detection of anti-Ro/SS-A and anti-La/SS-B antibodies: A comparison of counterimmunoelectrophoresis with immunoblot, ELISA, and RNA-precipitation assays. J Immunol Methods 1990;133:215-26.
17. Markusse HM, Veldhoven CHA, Swaak AJG, Smeenk RT: The clinical significance of the detection of anti-Ro/SS-A and anti-La/SS-B autoantibodies using purified recombinant proteins in primary Sjögren's syndrome. Rheumatol Int 1993;13:147-50.
18. McCauliffe DP, Yin H, Wang L, Lucas L: Autoimmune sera react with multiple epitopes on recombinant 52 and 60 kDa Ro(SSA) proteins. J Rheumatol 1994;21:1073-80.
19. Slobbe RL, Pruijn GJM, Damen WGM, Van Der Kemp JWCM, Van Venrooj WJ: Detection and occurrence of the 60- and 52-kD Ro (SS-A) antigens and of autoantibodies against these proteins. Clin Exp Immunol 1991;86:99-105.
20. Waterhouse JP, Doniach I: Post-mortem prevalence of focal lymphocytic adenitis of the submandibular gland. J Pathol Bacteriol 1966;91:53-64.
21. Chisolm DM, Mason DK: Labial salivary gland biopsy in Sjögren's disease. J Clin Pathol 1968;21:656-60.
22. Daniels TE: Labial salivary gland biopsy in Sjögren's syndrome. Assessment as a diagnostic criterion in 362 suspected cases. Arthritis Rheum 1984;21:147-56.
23. Smith DB, Corcoran LM: Expression and purification of glutathione S-transferase fusion proteins. In: Ausubel FM, Brent R, Kingston RE, et al, eds. Current Protocols in Molecular Biology. New York: John Wiley, 1990:7.1-7.8.
24. Satoh M, Ajmani AK, Ogasawara T, et al: Autoantibodies to RNA polymerase II are common in systemic lupus erythematosus and overlap syndrome. J Clin Invest 1996;94:1981-9.
25. Satoh M, Langdon JJ, Hamilton KJ, et al: Distinctive immune response patterns of human and murine autoimmune sera to U1 small nuclear rihonucleoprotein C protein. J Clin Invest 1996;97:2619-26.
26. Bozic B, Pruijn GJM, Rozman B, Van Venrooj WJ: Sera from patients with rheumatic diseases recognize different epitope regions on the 52-kD Ro/SS-A protein. Clin Exp Immunol 1993;94:227-35.
27. Buyon JP, Slade SG, Reveille JD, Hamel JC, Chan EKL: Autoantibody responses to the "native" 52 kD SS-A/Ro protein in neonatal lupus syndromes, systemic lupus erythematosus and Sjögren's syndrome. J Immunol 1994;152:3675-84.
28. Yell JA, Wang L, Yin H, McCauliffe DP: Disparate locations of the 52 and 60 kD Ro/SS-A antigens in cultured human keratinocytes. J Invest Dermatol 1996;107:622-6.
29. Keech CL, McCluskey J, Gordon TP: Transfection and overexpression of the human 60-kDa Ro/SS-A autoantigen in HEp-2 cells. Clin Immunol Immunopathol 1994;73:146-51.
30. Peek R, Pruijn GJM, van der Kemp AJW, van Venrooij WJ: Subcellular distribution of Ro ribonucleoprotein complexes and their constituents. J Cell Sci 1993;106:929-35.
31. Meilof JF, Frohn-Mulder IME, Stewart PA, et al: Maternal autoantibodies and congenital heart block: No evidence for the existence of a unique heart block-associated anti-Ro/SS-A autoantibody profile. Lupus 1993;2:239-46.
32. Tsuzaka K, Fujii T, Akizuki M, et al: Clinical significance of antibodies to native or denatured 60-kD or 52-kD Ro/SS-A proteins in Sjögren's syndrome. Arthritis Rheum 1994;37:88-92.
33. Meilof JF: Autoantibodies against small cytoplasmic ribonucleoproteins: The anti-Ro/SS-A and anti-La/SS-B autoimmune response. Rheumatol Int 1992;12:129-40.
34. Keech CL, Gordon TP, McCluskey J: Cytoplasmic accumulation of the 52 kDa Ro/SS-A nuclear autoantigen in transfected cell lines. J Autoimmun 1995;8:699-712.